Stakeholders: Lawmakers Should Ask CMS To Withdraw Part B Drug-Pay Demo

As House lawmakers consider what steps to take regarding CMS' Part B drug-pay demo, more than 300 oncologists, specialty doctors, biotechnology groups and others on Thursday (March 17) urged House and Senate leadership to ask CMS to withdraw its proposed Part B drug-pay demonstration. "A Center for Medicare & Medicaid Innovation (CMMI) initiative that focuses on costs rather than patients and health care quality, implemented based on primary care service areas, rather than the unique challenges of patients, is misguided...